Detection of Circulating Hepatocellular Carcinoma Cells with SSX Gene Mrna As Tumor Marker

MOU Dongcheng,LENG Xisheng,ZHAO Li,PENG Jirun

DOI: https://doi.org/10.3969/j.issn.1006-5709.2005.05.024

2005-01-01

Abstract:Objective To evaluate the clinical significance of the detection of circulating hepatocellular carcinoma (HCC) cells by using SSX gene mRNA as tumor markers Methods The expression of SSX mRNA was detected using RT PCR (steptown PCR) in peripheral blood mononuclear cells (PBMC) from 42 HCC patients and 30 healthy volunteers The relationship between SSX mRNA in PBMC of HCC patients and related clinical data was analyzed Results SSX gene transcripts were detectable in 85 7% (36/42) of HCC samples, while no expression of SSX gene was detected in the corresponding adjacent non HCC tissues, liver cirrhosis tissues and normal liver tissues In the PBMC of 42 HCC patients, 40 5% (17 out of 42) samples had expression of SSX gene transcripts In the patients in which tumor tissues did not express SSX gene transcripts,the corresponding SSX gene transcripts was undetectable in their PBMC either There was no expression of SSX genes in the PBMC from the 30 healthy donors No relationship was found between the expression of SSX genes in the PBMC and clinical parameters such as age, sex, tumor size, degree of tumor differentiation, serum α fetoprotein level and infection of hepatitis B virus or hepatitis C virus ( P 0 05) However, the positive expression of SSX genes in the PBMC had close correlation with prognosis of HCC patients Metastasis and/or recurrence took place in 50% (8 out of l6) patients with positive expression of SSX genes in their PBMC,while only 10 5% (2 out of l9) patients with negative expression of SSX genes in their PBMC developed metastasis and/or recurrence ( P =0 028) Conclusion SSX genes mRNA may be used as specific tumor markers for the detection of the circulating HCC cells